Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026)

Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 4.78%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 9.30%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 20.35%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -14.75%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 15.83%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn 5.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.50%
Dec 31, 2025 123.56%
Sep 30, 2025 60.13%
Jun 30, 2025 -2.81%
Mar 31, 2025 -56.76%
Dec 31, 2024 28.36%
Sep 30, 2024 -11.28%
Jun 30, 2024 -30.47%
Mar 31, 2024 -35.35%
Dec 31, 2023 -3.34%
Sep 30, 2023 -7.46%
Jun 30, 2023 -33.11%
Mar 31, 2023 2.76%
Dec 31, 2022 -29.09%
Sep 30, 2022 -34.96%
Jun 30, 2022 -48.85%
Mar 31, 2022 -162.12%
Dec 31, 2021 -25.99%
Sep 30, 2021 -0.69%
Jun 30, 2021 37.10%